Past Medical History: Rheumatic heart disease with 2-3+ MR, minimal MS (valve area 1.3 cm2), [**1-22**]+ tricuspid regurgitation and mild pulmonary hypertension RVE/[**Last Name (un) **] with IVC dilation by [**Last Name (un) 113**] Global RV dysfunction AI Prior IVDA-currently methadone clinic, stopped drugs 1.5 yrs ago ETOH abuse-stopped about 1.5 yrs ago Atypical chest pain PAF-on Coumadin last dose [**2134-1-24**] Chronic anemia Hepatitis C c/b liver fibrosis->followed by Dr. [**Last Name (STitle) 86971**] False Positive Syphilis Test Fibromyalgia Migraines IBS GERD Prior suicide attempt PTSD Pleural effusion s/p evacuation Bipolar Disorder Arthritis Acid reflux Breast Lumpectomy Endometriosis s/p laparoscopy Syncope/fall -approx [**2130**] Hypoglycemia Cholecystectomy Hysterectomy Tonsillectomy Endometriosis s/p laparoscopy s/p tubal ligation s/p lumpectomy from breast   Social History: Lives with:husband- [**Name (NI) **] Occupation: unemployed Tobacco:1.5ppd x 30 years ETOH:none in 1.5 yrs Rec drugs: none in 1.5 yrs.
H/o IVDA and cocaine use in past   Family History: father died of an MI mother died of heart problems Brother died in his 50s from heart problems   Physical Exam: Pulse:76 Resp:18 O2 sat:99% RA  pO2 76 on 2L NC B/P  Right: 113/89   Left: Height:5'1"     Weight: 67.3 kg  General: NAD, alert and cooperative Skin: Dry [x] intact [x] HEENT: PERRLA [x] EOMI [x] Neck:  Supple [x] Full ROM [x] Chest: Lungs clear bilaterally [x] Heart: RRR [x]  Irregular []  Murmur [**1-24**] HSM Abdomen: Soft [x] non-distended [x] non-tender [x]  bowel sounds + sl.
LE Neuro: Grossly intact Pulses: Femoral      Right: 2+  Left: 2+ DP           Right: 1+  Left: 1+ PT           [**Name (NI) 167**]: 1+  Left: 1+ Radial       Right: 2+  Left: 2+  Carotid Bruit        Right: no   Left: no   Pertinent Results: [**2134-2-16**] 05:10AM BLOOD WBC-6.5 RBC-3.15* Hgb-9.4* Hct-27.8* MCV-89 MCH-29.8 MCHC-33.6 RDW-17.4* Plt Ct-215 [**2134-1-31**] 09:00PM BLOOD WBC-5.4 RBC-4.35 Hgb-13.1 Hct-36.6 MCV-84# MCH-30.1 MCHC-35.8* RDW-15.8* Plt Ct-151 [**2134-2-1**] 12:32PM BLOOD Neuts-89.2* Lymphs-9.1* Monos-1.1* Eos-0.5 Baso-0.1 [**2134-2-16**] 05:10AM BLOOD Plt Ct-215 [**2134-2-16**] 05:10AM BLOOD PT-18.1* PTT-28.7 INR(PT)-1.6* [**2134-1-31**] 09:00PM BLOOD PT-13.3 PTT-34.7 INR(PT)-1.1 [**2134-1-31**] 09:00PM BLOOD Plt Ct-151 [**2134-2-16**] 05:10AM BLOOD Glucose-108* UreaN-42* Creat-0.8 Na-133 K-3.6 Cl-96 HCO3-28 AnGap-13 [**2134-2-15**] 05:40PM BLOOD Glucose-119* UreaN-50* Creat-1.0 Na-133 K-4.6 Cl-95* HCO3-28 AnGap-15 [**2134-2-1**] 02:05PM BLOOD UreaN-8 Creat-0.6 Na-136 K-4.2 Cl-104 HCO3-27 AnGap-9 [**2134-1-31**] 09:00PM BLOOD Glucose-92 UreaN-9 Creat-0.7 Na-135 K-4.5 Cl-99 HCO3-29 AnGap-12 [**2134-2-9**] 03:04AM BLOOD ALT-17 AST-37 LD(LDH)-525* AlkPhos-67 TotBili-1.4 [**2134-1-31**] 09:00PM BLOOD ALT-41* AST-49* LD(LDH)-224 AlkPhos-87 Amylase-66 TotBili-0.6 [**2134-2-3**] 03:29AM BLOOD Lipase-11 [**2134-2-16**] 05:10AM BLOOD Calcium-9.5 Phos-3.3 Mg-2.4 [**2134-1-31**] 09:00PM BLOOD %HbA1c-5.9 eAG-123 [**2134-2-5**] 05:14AM BLOOD Osmolal-276 [**2134-2-5**] 09:23AM BLOOD TSH-1.7 [**2134-2-5**] 09:23AM BLOOD T4-9.0 T3-78* [**2134-2-5**] 09:23AM BLOOD Cortsol-36.1*  CHEST TWO VIEWS, [**2134-2-14**] FINDINGS: Two views of the chest compared to prior study from [**2134-2-11**].
Echocardiographic Measurements Results  Measurements  Normal Range Left Atrium - Long Axis Dimension:  *4.4 cm  <= 4.0 cm Left Ventricle - Septal Wall Thickness:  1.1 cm  0.6 - 1.1 cm Left Ventricle - Inferolateral Thickness:  1.0 cm  0.6 - 1.1 cm  Left Ventricle - Diastolic Dimension:  4.0 cm  <= 5.6 cm Left Ventricle - Systolic Dimension:  2.5 cm Left Ventricle - Fractional Shortening:  0.38  >= 0.29 Left Ventricle - Ejection Fraction:  70%  >= 55% Left Ventricle - Lateral Peak E':  *0.04 m/s  > 0.08 m/s Left Ventricle - Septal Peak E':  *0.03 m/s  > 0.08 m/s Left Ventricle - Ratio E/E':  *40  < 15 Aorta - Sinus Level:  2.4 cm  <= 3.6 cm Aortic Valve - Peak Velocity:  1.8 m/sec  <= 2.0 m/sec Aortic Valve - LVOT diam:  2.0 cm Mitral Valve - Peak Velocity:  1.4 m/sec Mitral Valve - Mean Gradient:  6 mm Hg Mitral Valve - E Wave:  1.4 m/sec Mitral Valve - A Wave:  0.7 m/sec Mitral Valve - E/A ratio:  2.00 Mitral Valve - E Wave deceleration time:  *400 ms  140-250 ms TR Gradient (+ RA = PASP):  7 mm Hg  <= 25 mm Hg  Findings LEFT ATRIUM: Mild LA enlargement.
LEFT VENTRICLE: Normal LV wall thickness, cavity size and regional/global systolic function (LVEF >55%).
Compared with the findings of the prior study (images reviewed) of [**2133-8-3**], the mitral and tricuspid valves have been replaced.
Completed preoperative workup and [**2134-2-1**] was brought to the operating room and underwent mitral valve and tricuspid valve replacements, see operative report for further details.
Her oxygen requirements increased and she continued to require aggressive diuresis and non invasive ventilation for few days.
Open from 6am to 1015am daily  Has received 45 mg daily while in the hospital [**Date range (1) 86974**]  20. coumadin and INR [**2-16**] coumadin 7.5 mg inr 1.6 [**2-15**] coumadin 4 mg   inr 1.8 [**2-14**] coumadin 5 mg   inr 1.9 [**2-13**] coumadin 2.5mg  inr 2.2 [**2-12**] coumadin 4 mg   inr 2.6 [**2-11**] coumadin 2.5mg  inr 2.7 [**2-10**] coumadin 2.5mg  inr 3.1 [**2-9**] coumadn  3mg    inr 2.2 [**2-8**] coumadin 5 mg   inr 1.9 [**2-7**] coumadin 5 mg   inr 1.5 [**2-6**] coumadin 5 mg   inr 1.4  nutriton had been poored and now improved with shakes (ensure) which contain vitamin K home doses prior to admission 5-7.5 mg daily 21.
indication Atrial fibrillation and pulmonary embolism Goal INR [**12-24**] First draw wendesday [**2-17**] Physician at rehab to monitor INR and dose coumadin based on results - please check monday and wednesday and friday for 3 weeks to maintain close monitoring due to liver disease and then twice a week Please arrange for coumadin management with PCP prior to discharge from rehab 22.
Outpatient Lab Work Chem 10 twice a week while on IV lasix  23. warfarin 5 mg Tablet Sig: Goal INR 2.0-3.0 Tablets PO once a day: dose based on INR by rehab physician [**Name Initial (PRE) **] [**Name10 (NameIs) **] draw [**2-17**] for further dosing .
indication Atrial fibrillation and pulmonary embolism Goal INR [**12-24**] First draw wendesday [**2-17**] Physician at rehab to monitor INR and dose coumadin based on results - please check monday and wednesday and friday for 3 weeks to maintain close monitoring due to liver disease and then twice a week Please arrange for coumadin management with PCP prior to discharge from rehab    Completed by:[**2134-2-16**
